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Acute external otitis is a polymicrobial infectious disease. 
Aim: The purpose of this study was to isolate, identify and 
determine the Antimicrobial susceptibility of organisms 
causing otitis externa (OE). Methods: twenty-seven swabs 
were taken from the ears of 27 patients with OE for culture 
and 22 microorganisms were isolate to evaluate sensitivity. In 
vitro susceptibility tests were performed by agar diffusion disk 
and results were interpreted according to Clinical Laboratory 
Standards. Results: 10 Ear cultures were positive for S. aureus 
, 8 for P. aeruginosa, 5 for P. aeruginosa and S. aureus 
and 4 for fungal organisms (Candida albicans e C. Krusei). 
Gentamicin and quinolones were active against all bacteria 
tested and significant resistance to amoxicillin/clavulanate was 
observed. The tested species of Candida had been sensitive 
to amphothericin B, nystatin, fluconazole and clotrimazole 
and resistant to miconazole. Conclusion: Acute external otitis 
is a polymicrobial infection and proper knowledge regarding 
microorganism etiology and susceptibility will contribute to 
rational antibiotic usage and treatment success.
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INTRODUCTION
Otitis externa is an inflammation on the skin of the 
external auditory canal, usually associated with secondary 
bacterial and/or fungal infection of macerated skin and 
subcutaneous cellular tissue. Many factors act, changing 
the most superficial skin layers, opening doors for infec-
tion to happen, making bacterial otitis externa the major 
cause of disease in the external ear1. Systemic conditions 
such as anemia, low vitamin concentration in the body, 
endocrine disorders - especially diabetes and many forms 
of dermatitis such as seborrhea, psoriasis and eczema may 
reduce resistance to infections in the external auditory 
canal, causing the development of otitis externa2.
To treat this disease we use ear drops with antibio-
tics and/or antifungal agents associated with anesthetic 
and/or anti-inflammatory agents, and systemic drugs are 
indicated should complications occur3. The goal of this 
study was to isolate and identify species of microbes in 
patients with clinical diagnosis of acute otitis externa, and 
the susceptibility of microorganisms to the antimicrobial 
drugs standardized in the antibiogram test.
MATERIALS AND METHODS
The patients were seen in public and private otorhi-
nolaryngology medical offices. Twenty seven patients 
diagnosed with acute otitis externa were selected regar-
dless of age and gender. We used Goldenber’s inclusion 
criteria4, which are: a diagnosis of otitis externa, no prior 
treatment and intact ear drum. The patients selected had 
material collected from the diseased ear by means of a 
swab by a trained professional and the material collected 
was transported in Stuart’s culture medium. The study was 
carried out following the regulatory standards and guide-
lines for research involving human beings, Resolution # 
196/19965 from the Ministry of Health and approved by 
the Ethics in Research Committee of the Lauro Wanderley 
University Hospital, protocol # 341, and the patient signed 
an informed consent form in order to be submitted to 
material collection and culture.
The cultures were randomly sent to three different 
labs and the in vitro susceptibility tests were carried out 
through the disc spread agar, and the results were inter-
preted following conventional clinical and laboratorial 
standards6-8.
RESULTS
The patients were seen in an otorhinolaryngology 
ward, regardless of age and gender, and were selected 
through clinical diagnosis, twenty seven patients with 
acute otitis externa. They had material collected from their 
diseased ear, and this material was submitted to bacterial 
culture and antibiogram study. Staphylococcus aureus were 
seen in 10 cultures (37%), Pseudomonas aeruginosa in 8 
cultures (29.6%), Pseudomonas aeruginosa and Staphylo-
coccus aureus together were seen in 5 cultures (18.5%), 
and Candida fungus was found in 4 cultures, (14.9%), in 
all cases, they were associated to Gram positive and Gram 
negative bacteria. This data is shown on Figure 1.
From the twenty seven cultures obtained in the 
present study, we isolated eight S. aureus strains, twelve 
P. aeruginosa strains, one Candida albicans strain and 
one C. krusei strain. The results from the susceptibility test 
for S. aureus can be seen on Table 1, for P. aeruginosa, 
on Table 2; and for fungii on Table 3. 
Table 1. Assessment of S. aureus strains obtained from patients with AOM in terms of their susceptibility to antimicrobial agents. S= sensitive - 
R= resistant i= intermediate x= not tested
Strain 1 Strain 2 Strain 3 Strain 4 Strain 5 Strain 6 Strain 7 Strain 8 Sensitivity %
Quinolones S S S S S S S S 100
Macrolides S R R R R R R S 25
Penicillin S R R R R R R R 12,5
Augmented Amoxicillin S S S R S S R S 75
Ampicillin S R R R R R R R 12,5
Amoxicillin S R R R R R R R 12,5
Cephalosporin1 S S S S S S S X 100
Cephalosporin2 S S S S S S S S 100
Cephalosporin 3 S S S S S S S X 100
Aminoglycoside S S S S S S S S 100
Chloramphenicol S S S S S S S S 100
Tetracycline S S R R S S X X 50
Vancomycin S S S S S S S S 100
Clindamycin S R S R R R R X 25
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Table 2. Antibiogram from Pseudomonas aeruginosa strains taken from patients with AOM. S= sensitive - R= resistant i= intermediate x= not 
tested
Strain 
1
Strain 2
Strain 
3
Strain 
4
Strain 
6
Strain 7
Strain 
8
Strain 
9
Strain 
10
Strain 
11
Strain 
12
Sensibi 
lidade %
Quinolones S S S S S S S S S S S S 100
Erythromycin R R R R R R R R R R R R -
Augmented 
Amox.
R R R R R R R R R R R R -
Ampicillin R R R R R R R R R R R R -
Amoxicillin R R R R R R R R R R R R -
Ceftazidime I I S I S I S I I I I I 25
Cefotaxime I I S I S I S I I I I I 25
Ceftriaxone I I S I S R S I I I I I 25
Lincomycin R R R R R R R X X R R R -
Tobramycin S S S S S X S S S S X X 100
Chloramphe-
nicol
R R I R I R R R R R R R -
Tetracycline R R R R R R R R R R R R -
Piperacillin/
Azobatan,
S S S S S R S S S S S S 91
Aztreonam S S S S S R S S S S S S 91
Imipenen, 
Meropenem
S S S S S S S S S S S S 100
Table 3. Antibiogram of the Candida strains in AOE patients. S= sensitive - R= resistant i= intermediate x= not tested
Candida albicans Candida krusei
Miconazole R R
Ketoconazole I I
Fluoconazole I S
Clotrimazole S I
Anphotericin B S I
Figure 1. Distribution of acute otitis externa etiological agents.
DISCUSSION
Otitis externa is one of the most commonly found 
diseases in otolaryngology wards, especially during the 
Summer time; affecting about 10% of the population9, 
regardless of gender and age10. It may be localized or 
diffused, acute or chronic11. The most commonly found 
bacterial agents are P. aeruginosa and S. aureus; and as 
far as fungii are concerned, the agents are Aspergillus and 
C.albicans2,11.
The results hereby achieved lead us to conclude 
that the microorganisms isolated and identified on the 
external auditory canal skin were P. aeruginosa and S. 
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aureus bacteria and Candida fungii, and considering 
the latter, Candida krusei was also found, which is not 
very frequently reported as a microbial agent associated 
with otitis; and this data is similar to what is found in the 
literature12.
Hwang et al.13 carried out a bacteriology study 
in 161 patients and they observed that Staphylococcus 
aureus was as frequent as Pseudomonas aeruginosa in 
otitis externa patients. This data rectify the findings of the 
present investigation, because in our study there was no 
statistically significant difference between P. aeruginosa 
and S. aureus.
Although P. aeruginosa is the most frequently found 
bacteria in otitis externa, the percentage of positive cultu-
res for S. aureus was very significant in numerous papers 
published, establishing both agents as the main ones res-
ponsible for infections in the external ear. In the present 
investigation there was a subtle predominance of S. aureus 
in relation to P. aeruginosa, and they were found together 
in 18.5% of the cases, which is very similar to what is found 
in the literature in regards of polymicrobial flora12.
The treatment of acute otitis externa is based on 
local debridement, use of ear drops with acidifying agents 
and/or antimicrobial agents and, in cases of intense 
edemas and/or purulent secretions, one would use oral 
anti-inflammatory and antimicrobial agents. The use of 
parenteral antimicrobial agents is indicated in cases of 
malignant otitis externa.
The most commonly used ear drops have in their 
formulas: antibiotics, hormonal anti-inflammatory agents 
and, in some products, anesthetics. The most used anti-
biotics are: aminoglycosides (gentamicin and neomycin), 
polymyxin B, chloramphenicol and quinolones (ofloxacin, 
ciprofloxacin).
Since the introduction of fluoroquinolones in the 
medical practice, in 1980, they have been successfully used 
in numerous infections, especially those caused by P. ae-
ruginosa, being added to the weaponry of ear drops14.
Ofloxacin and ciprofloxacin which are available as 
ear drops and, ciprofloxacin, also in ophthalmic solutions, 
can also be used to treat the auditory canal. The greatest 
advantage of these agents is the absence of ototoxic effects. 
Despite the systemic use of fluoroquinolones be usually 
contraindicated in children, topical solutions are safe and 
efficatious14.
Gentamicin and polymyxin B were the most effec-
tive ear drops to treat acute otitis externa against P. aeru-
ginosa, according to a study carried out by Loh et al.15, in 
Singapore, with 107 patients. In the present investigation, 
all the P. aeruginosa strains exposed to gentamicin proved 
to be sensitive. However, we did not test polymyxin B, 
since the labs were not standardized to test this drug in 
the antibiogram.
In assessing the susceptibility of P. aeruginosa 
strains taken from patients with acute otitis externa, three 
were sensitive and nine had intermediate sensitivity to 
ceftazidime, while all the 12 strains were sensitive to ci-
profloxacin. Two strains were resistant and one strain had 
intermediate sensitivity to neomycin, we did not observe 
resistance to fluoroquinolones; and all the strains exposed 
to gentamicin were sensitive.
Chloramphenicol is also used as ear drops; howe-
ver, in the present investigation the high resistance rate 
of P. aeruginosa towards this drug in the susceptibility 
test, including augmented amoxicillin, these drugs used 
per os for ear diseases, as first line options, especially in 
the treatment of otitis media, must not be considered in 
the oral treatment of otitis externa, according to this sus-
ceptibility study, which share the same resistance findings 
from other papers11,16.
As far as S. aureus is concerned, chloramphenicol 
was very active, as were quinolones, fluoroquinolones, 
neomycin and oxacillin, and one strain was resistant to 
gentamicin.
There was resistance to amoxicillin; however, when 
associated with augmented amoxicillin, its action was 
satisfactory. Second and third generation cephalosporins 
were active against the bacteria tested, and it can be used 
as a treatment option. It is important to notice that because 
of the diversified germ flora and variable susceptibility, in 
the complication of otitis externa it is paramount to order 
an antibiogram test in order to achieve a more efficient 
treatment. 
There have been numerous progresses in the treat-
ment of fungal infections with systemic antifungal drugs, 
such as polyenes (oral nystatin and intravenous ampho-
thericin B) and imidazole agents (miconazole - oral and IV 
and oral ketoconazole). Ear drops with antifungal agents, 
especially those with imidazole agents have excellent 
action in otolaryngology; however, since otitis media is 
usually caused by a polymicrobial flora, with fungi and 
bacteria together, it would be very important to use topical 
agents with broad spectrum17.
There are very few ear drops to treat otomycosis 
today in the market, usually we have to use dermatologic 
creams or lotions for its treatment. The present study iso-
lated two strains of Candida, a fungus very much found 
in otomycosis, in all cases associated to gram positive and 
gram negative bacteria. Since it is usual to find a poly-
microbial flora in otomycosis, it would be better to use a 
topical medication with antifungal and antibacterial agents, 
which is not very much found in clinical practice.
The Candida species found in this study were all 
sensitive to Amphothericin B, nystatin, fluconazole and 
clotrimazole and resistant to miconazole.
Otomycosis represents a small percentage of the 
clinical otitis externa and, in contrast with external bacterial 
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otitis, there are not too many specific topic preparations 
for its treatment.
We carried out an in vitro study of the susceptibility 
of the fungii responsible for otomycosis and we observed a 
good antifungal activity of clotrimazole and nystatin. As far 
as nystatin is concerned, such data match the ones found in 
the present investigation, since the Candida species were 
all susceptible to these antifungal medication18.
Imidazole derivatives, miconazole and clotrima-
zole may be successfully used in otomycosis in topical 
solutions17. However, in the present investigation the two 
strains were resistant to miconazole and one strain had 
intermediate sensitivity to clotrimazole. Among imidazole 
derivatives, ketoconazole represents a revolutionary anti-
fungal agent, especially against Candida albicans, besides 
having low toxicity17; however, in the present study it 
showed intermediate sensitivity.
One important finding from the present investi-
gation was that some antibiotic agents which are part of 
ear drops were not tested in some antibiograms, in other 
words, they were not part of the laboratory routine and 
there were no standardizing for the antibiotic agents that 
were tested. 
CONCLUSION
Acute otitis externa had a polymicrobial etiology, 
with a predominance of S. aureus, P.aeruginosa and 
Candida. The bacteria assessed were resistant to penicillin 
and augmented amoxicillin and had good sensitivity to 
most antifungal agents. Therefore, a better knowledge of 
the etiology and the susceptibility of the microorganisms 
responsible for the acute otitis externa contributes to the ju-
dicial use of antimicrobial agents and treatment success. 
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